Marco Sposito

495 citations
38 papers · 233 indexed · h-index 10
Topics
Cancer survivorship and care (11 papers)Lung Cancer Treatments and Mutations (10 papers)Cancer Diagnosis and Treatment (7 papers)
Partner nations
ItalyUnited StatesFrance

In The Last Decade

Marco Sposito

30 papers receiving 222 citations

Peers

Marco Sposito
Comparison fields: 5 of 55
  • Oncology 129
  • Pulmonary and Respiratory Medicine 70
  • Neurology 43
  • Physiology 36
  • Molecular Biology 30
Replace Christopher J. Schwartz with:
Christopher J. Schwartz United States
Linda Koehler United States
Atsushi Fukuuchi Japan
Naoki Tashiro Japan
Jean-François Fléjou France
Pamela Correa Sweden
Roberto Maria Romano Italy
Shiho Kuji Japan
Marco Sposito relative to Christopher J. Schwartz United States Christopher J. Schwartz's profile →
Citations per field
00.5×7.2×
Christopher J. Schwartz · 1×
Citations per year

Countries citing papers authored by Marco Sposito

Since Specialization
Citations

This map shows the geographic impact of Marco Sposito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Sposito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Sposito more than expected).

Fields of papers citing papers by Marco Sposito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Sposito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Sposito. The network helps show where Marco Sposito may publish in the future.

Co-authorship network of co-authors of Marco Sposito

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Sposito. A scholar is included among the top collaborators of Marco Sposito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Sposito. Marco Sposito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 2
6 8
7 1
8 4
9 1
10 1
11 14
12 19
13 2
14 13
15 0
16 9
17 4
18 8
19 15
20 1

About Marco Sposito

Marco Sposito is a scholar working on Oncology, Geriatrics and Gerontology and Otorhinolaryngology, having authored 38 papers that have together received 233 indexed citations. Recurring topics across this work include Cancer survivorship and care (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Diagnosis and Treatment (7 papers). The work is most often cited by research in Oncology (129 citations), Neurology (43 citations) and Dermatology (24 citations). Marco Sposito has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Michèle Milella, Alice Avancini, Sara Pilotto, Lorenzo Belluomini, Ilaria Trestini, Daniela Tregnago, Antônio Rossi, Emilio Bria, Federico Schena and Jessica Menis. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026